Show simple item record

dc.contributor.authorChoi, Tae-Young
dc.contributor.authorAng, Lin
dc.contributor.authorJun, Ji Hee
dc.contributor.authorAlræk, Terje
dc.contributor.authorBirch, Stephen
dc.contributor.authorLu, Weidong
dc.contributor.authorLee, Myeong Soo
dc.date.accessioned2023-03-01T07:05:54Z
dc.date.available2023-03-01T07:05:54Z
dc.date.created2022-10-13T12:49:11Z
dc.date.issued2022
dc.identifier.citationCancers- 2022, 14(18), 4419.en_US
dc.identifier.issn2072-6694
dc.identifier.urihttps://hdl.handle.net/11250/3054807
dc.description.abstractBreast cancer (BC) is the most common cancer in women and is a serious threat to women’s health. Cancer-related fatigue (CRF) is a distressing symptom in BC patients during and after chemotherapy or radiation therapy that severely affects quality of life (QoL). AT is widely used for fatigue management. However, the effect of AT on CRF is still uncertain. This study aimed to evaluate the efficacy and safety of AT in the management of CRF in patients with BC. Eleven databases were searched through June 2022. Two researchers independently performed the database search, study selection, data extraction, and risk of bias assessment. Study selection was performed based on predefined Participants, Intervention, Comparators, Outcomes, Study design (PICOS) criteria, and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed when reporting the results. A meta-analysis was performed according to the Cochrane systematic review method using RevMan 5.3. A total of 12 studies including a total of 1084 participants were included. The results showed that AT had a beneficial effect compared with sham AT (n = 256, SMD = −0.26, 95% CI [−0.51, −0.01], p = 0.04, I2 = 0%) and a long-term effect on fatigue score (n = 209, MD = −0.32, 95% CI [–0.59, −0.04], p = 0.02, I2 = 0%). Meta-analysis showed that AT had a beneficial effect compared with usual care (UC) on fatigue scores (n = 238, SMD = −0.39, 95% CI [−0.66 to −0.12], p = 0.005, I2 = 0%). Of the 12 articles, 3 articles were judged as having a low risk of bias in all domains and hence were of high quality. No serious adverse effects were identified. AT is an effective and safe treatment for CRF, and AT is more effective than sham AT or UC or wait-list control (WLC). Nevertheless, the methodological quality of most of these studies was low, and the included studies/sample sizes were small, so the ability to derive decisive implications was limited. Further research is needed to confirm these findings.en_US
dc.language.isoengen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectakupunkturen_US
dc.subjectbrystkreften_US
dc.subjectkreftrelatert fatigueen_US
dc.subjectcancer-related fatigueen_US
dc.subjectbreast canceren_US
dc.subjectacupunctureen_US
dc.titleAcupuncture for managing cancer-related fatigue in breast cancer patients: A systematic review and meta-analysisen_US
dc.title.alternativeAcupuncture for managing cancer-related fatigue in breast cancer patients: A systematic review and meta-analysisen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.volume14en_US
dc.source.journalCancersen_US
dc.source.issue18en_US
dc.identifier.doi10.3390/cancers14184419
dc.identifier.cristin2061130
dc.source.articlenumber4419en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal